Literature DB >> 21558565

Changes in executive function after acute bouts of passive cycling in Parkinson's disease.

Angela L Ridgel1, Chul-Ho Kim, Emily J Fickes, Matthew D Muller, Jay L Alberts.   

Abstract

Individuals with Parkinson's disease (PD) often experience cognitive declines. Although pharmacologic therapies are helpful in treating motor deficits in PD, they do not appear to be effective for cognitive complications. Acute bouts of moderate aerobic exercise have been shown to improve cognitive function in healthy adults. However, individuals with PD often have difficulty with exercise. This study examined the effects of passive leg cycling on executive function in PD. Executive function was assessed with Trail-Making Test (TMT) A and B before and after passive leg cycling. Significant improvements on the TMT-B test occurred after passive leg cycling. Furthermore, the difference between times to complete the TMT-B and TMT-A significantly decreased from precycling to postcycling. Improved executive function after passive cycling may be a result of increases in cerebral blood flow. These findings suggest that passive exercise could be a concurrent therapy for cognitive decline in PD.

Entities:  

Mesh:

Year:  2011        PMID: 21558565     DOI: 10.1123/japa.19.2.87

Source DB:  PubMed          Journal:  J Aging Phys Act        ISSN: 1063-8652            Impact factor:   1.961


  21 in total

1.  Effects of a low-resistance, interval bicycling intervention in Parkinson's Disease.

Authors:  Mehmet Uygur; Maria Bellumori; Christopher A Knight
Journal:  Physiother Theory Pract       Date:  2017-08-16       Impact factor: 2.279

2.  Establishing Equivalent Aerobic Exercise Parameters Between Early-Stage Parkinson's Disease and Pink1 Knockout Rats.

Authors:  Michael F Salvatore; Isabel Soto; Ella A Kasanga; Rachael James; Marla K Shifflet; Kirby Doshier; Joel T Little; Joshia John; Helene M Alphonso; J Thomas Cunningham; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Treatment of psychosis and dementia in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

4.  The effect of forced-exercise therapy for Parkinson's disease on motor cortex functional connectivity.

Authors:  Erik B Beall; Mark J Lowe; Jay L Alberts; Anneke M M Frankemolle; Anil K Thota; Chintan Shah; Michael D Phillips
Journal:  Brain Connect       Date:  2013-02-25

5.  Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Roger L Albin; Martijn L T M Müller; Kelvin Chou
Journal:  US Neurol       Date:  2011-11-01

6.  Effects of Exercise on Non-motor Symptoms in Parkinson's Disease.

Authors:  Amy W Amara; Adeel A Memon
Journal:  Clin Ther       Date:  2017-12-01       Impact factor: 3.393

7.  Enhanced Exercise Therapy in Parkinson's disease: A comparative effectiveness trial.

Authors:  Angela L Ridgel; Benjamin L Walter; Curtis Tatsuoka; Ellen M Walter; Kari Colón-Zimmermann; Elisabeth Welter; Martha Sajatovic
Journal:  J Sci Med Sport       Date:  2015-02-07       Impact factor: 4.319

8.  The effects of exercise on cognition in Parkinson's disease: a systematic review.

Authors:  Danielle K Murray; Matthew A Sacheli; Janice J Eng; A Jon Stoessl
Journal:  Transl Neurodegener       Date:  2014-02-24       Impact factor: 8.014

9.  Executive Function Improves Following Acute Exercise in Adults with Down Syndrome.

Authors:  Shannon Ringenbach; Nathanial Arnold; Brandon Myer; Claire Hayes; Kahyun Nam; Chih-Chia Chen
Journal:  Brain Sci       Date:  2021-05-13

10.  Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.

Authors:  Ergun Y Uc; Kevin C Doerschug; Vincent Magnotta; Jeffrey D Dawson; Teri R Thomsen; Joel N Kline; Matthew Rizzo; Sara R Newman; Sonya Mehta; Thomas J Grabowski; Joel Bruss; Derek R Blanchette; Steven W Anderson; Michelle W Voss; Arthur F Kramer; Warren G Darling
Journal:  Neurology       Date:  2014-07-02       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.